Clinical Trial 16833

Bourbonnais, IL 60914


Study Summary:

A 12-week, randomized, double blind, placebo controlled study of a new therapy in subjects with irritable bowel syndrome.


Qualified Participants Must:

• Have been diagnosed with Irritable Bowel Syndrome
• Be willing to comply with the study protocol


Qualified Participants May Receive:

Compensation, free Study Medication and free study related healthcare.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.